CHI Advisors as of June 30, 2020
Portfolio Holdings for CHI Advisors
CHI Advisors holds 19 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pliant Therapeutics (PLRX) | 40.0 | $75M | 2.3M | 32.46 | |
| Larimar Therapeutics (LRMR) | 14.7 | $28M | 2.1M | 12.85 | |
| Keros Therapeutics (KROS) | 11.6 | $22M | 580k | 37.51 | |
| Repare Therapeutics Ord (RPTX) | 9.9 | $19M | 600k | 31.02 | |
| Orchard Therapeutics Ads | 9.4 | $18M | 2.9M | 6.00 | |
| Precision Biosciences Ord | 4.3 | $8.0M | 960k | 8.33 | |
| Ovid Therapeutics (OVID) | 2.1 | $4.0M | 544k | 7.37 | |
| Akouos | 2.1 | $3.9M | 175k | 22.50 | |
| Kezar Life Sciences (KZR) | 0.9 | $1.8M | 341k | 5.18 | |
| Myokardia | 0.7 | $1.3M | 14k | 96.59 | |
| Livongo Health | 0.6 | $1.1M | 15k | 75.20 | |
| G1 Therapeutics | 0.6 | $1.1M | 44k | 24.25 | |
| Adverum Biotechnologies | 0.6 | $1.0M | 50k | 20.88 | |
| Ultragenyx Pharmaceutical (RARE) | 0.5 | $1.0M | 13k | 78.23 | |
| Corvus Pharmaceuticals (CRVS) | 0.5 | $990k | 364k | 2.72 | |
| Blueprint Medicines (BPMC) | 0.5 | $936k | 12k | 78.00 | |
| Global Blood Therapeutics In | 0.4 | $821k | 13k | 63.15 | |
| Bluebird Bio (BLUE) | 0.3 | $488k | 8.0k | 61.00 | |
| Unum Therapeutics Ord | 0.2 | $433k | 941k | 0.46 |
